One-year versus five-year hospital readmission after ischemic stroke and TIA by Bjerkreim, Anna Therese et al.
RESEARCH ARTICLE Open Access
One-year versus five-year hospital
readmission after ischemic stroke and TIA
Anna Therese Bjerkreim1,2* , Halvor Naess1,2,3, Andrej Netland Khanevski2,3,4, Lars Thomassen1,2,
Ulrike Waje-Andreassen2 and Nicola Logallo1,5
Abstract
Background: The burden of hospital readmission after stroke is substantial, but little knowledge exists on factors
associated with long-term readmission after stroke. In a cohort comprising patients with ischemic stroke and
transient ischemic attack (TIA), we examined and compared factors associated with readmission within 1 year and
first readmission during year 2–5.
Methods: Patients with ischemic stroke or TIA who were discharged alive between July 2007 and October 2012,
were followed for 5 years by review of medical charts. The timing and primary cause of the first unplanned
readmission were registered. Cox regression was used to identify independent risk factors for readmission within 1
year and first readmission during year 2–5 after discharge.
Results: The cohort included 1453 patients, of whom 568 (39.1%) were readmitted within 1 year. Of the 830 patients that
were alive and without readmission 1 year after discharge, 439 (52.9%) were readmitted within 5 years. Patients readmitted
within 1 year were older, had more severe strokes, poorer functional outcome, and a higher occurrence of complications
during index admission than patients readmitted during year 2–5. Cardiovascular comorbidity and secondary preventive
treatment did not differ between the two groups of readmitted patients. Higher age, poorer functional outcome, coronary
artery disease and hypertension were independently associated with readmission within both 1 year and during year 2–5.
Peripheral artery disease was independently associated with readmission within 1 year, and atrial fibrillation was associated
with readmission during year 2–5.
Conclusions: More than half of all patients who survived the first year after stroke without any readmissions
were readmitted within 5 years. Patients readmitted within 1 year and between years 2–5 shared many risk
factors for readmission, but they differed in age, functional outcome and occurrence of complications during
the index admission.
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Background
Stroke survivors carry a high risk of new diseases due to
functional disability, neurological deficits and pre-existing
cardiovascular risk factors and comorbidity [1]. Readmis-
sions after stroke are frequent, particularly during the first
3 months after stroke when more than half of all patients
readmitted within 1 year presents [2–4]. The neurological
and functional impairments often improve during the first
year after stroke, but the number of readmitted patients
steadily increases in the chronic phase, and between 67
and 83% of all stroke patients have been readmitted within
5 years [4–6]. Despite this, less is known about the
long-term risk of readmission for stroke patients who sur-
vive the early phase after stroke without any readmissions.
Several studies have examined predictors for readmission
after stroke. Data on causes of readmissions after stroke
can be used to prevent future avoidable readmissions. Al-
though the study findings are inconsistent, factors associ-
ated with 1-year readmission include older age [2, 7–10], a
history of stroke [2], diabetes mellitus, [11] coronary artery
disease [2], in-hospital complications [2, 10], longer length
of hospital stay [2, 7, 11], and poor functional outcome [2,
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11]. Predictors of readmission in the chronic phase of
stroke after 1 year have not been identified. Furthermore, it
is possible that patients readmitted within the first year dif-
fer from patients that experience the first readmission later,
as the early readmission may to a higher extent be directly
related to acute post-stroke complications and the
post-acute stroke treatment, and patients readmitted within
the first year may be more severely impaired than patients
readmitted later.
The aims of our study were to identify 1) predictors of
readmission within 1 year, 2) predictors of first readmis-
sion during year 2–5, and 3) factors differing between
patients readmitted within 1 year and patients with the
first readmission during year 2–5 after ischemic stroke
and transient ischemic attack (TIA). We hypothesized
that patients readmitted within the first year are more
affected by acute complications during the index admis-
sion, have more severe strokes and poorer functional
outcome than patients readmitted later, and that trad-
itional cardiovascular risk factors are more prominent in
patients readmitted within the first year after stroke.
Methods
All patients > 18 years of age admitted to the Stroke Unit
at the Department of Neurology with ischemic stroke or
TIA, Haukeland University Hospital from July 1, 2007 to
September 31, 2012, were prospectively registered in the
Bergen NORSTROKE Registry. The Stroke Unit serves a
well-defined geographical area with approximately
275,000 inhabitants. For the present study, we excluded all
patients with residence outside the hospital catchment
area due to difficulties of long-term follow-up. We also ex-
cluded patients who died during the index admission and
patients who were discharged to palliative care.
Ischemic stroke was defined as an episode of neuro-
logic deficit lasting > 24 h or clinical symptoms of TIA
where computed tomography or magnetic resonance im-
aging showed acute infarctions related to the initial
symptoms [12]. TIA was diagnosed clinically and was
defined as transient focal cerebral dysfunction < 24 h
with no objective evidence of acute brain infarction on
imaging. Duplex ultrasound of the carotid arteries, echo-
cardiogram, Holter monitoring, echocardiography and
serology were obtained during hospital admission.
Stroke etiology was classified by an experienced stroke
neurologist (HN) according to the Trial of Org 10,172 in
Acute Stroke Treatment (TOAST) criteria [13]. Stroke
severity was determined by the National Institutes of
Health Stroke Scale (NIHSS) score on admission and
day 7, or at discharge if earlier. Short-term functional
outcome was determined by modified Rankin Scale
(mRS) and Barthel Index on day 7 or at discharge if earl-
ier. Clinical characteristics, treatment, comorbidity, med-
ical history, in-hospital complications and discharge
destination were registered. Secondary prevention was
based on the Norwegian guidelines for stroke treat-
ment [14].
Information on readmission and death within 5 years
after discharge was collected by review of the medical
records from all nine hospitals in the region of the
Western Norway Regional Health Authorities. Readmis-
sion was defined as the first unplanned admission for
any cause to any hospital department after the index ad-
mission. The timing and primary cause of the first re-
admission were registered, and readmitted patients were
divided into two groups: first readmission within 1 year
after discharge, and first readmission within year 2–5.
Causes of readmission were categorized as recurrent
stroke, stroke-related event (including neurological de-
terioration, hemorrhagic transformation of cerebral in-
farction, neurological complications after carotid
endarterectomy, and suspected stroke or TIA with no
specific final diagnosis), seizure, cardiac disease, infec-
tion, fracture, gastrointestinal hemorrhage, venous
thromboembolism, and other cause. Hemorrhagic trans-
formation was defined as petechial or confluent
hemorrhage in the same area as the primary infarction.
The study was approved by the Regional Ethics Com-
mittee for Medical and Health Research Ethics in West-
ern Norway (REC West). Written informed consent was
obtained from all patients. In cases where patients suf-
fered severe strokes and were not able to give informed
consent, this was obtained from their legally authorized
representatives as required by the Regional Ethics Com-
mittee for Medical and Health Research Ethics in West-
ern Norway.
Statistics
Baseline characteristics were examined by using the χ2
test for categorical variables and Student’s t-test or
Mann-Whitney’s U-test for the continuous variables as
appropriate. A Kaplan-Meier failure curve was made to
demonstrate the incidence of readmission over time, and
the log-rank test was used to compare the incidence of
readmission between ischemic stroke and TIA. Cox re-
gression analyses were used to examine factors associ-
ated with readmission within 1 year and first
readmission during year 2–5 after discharge with back-
ward selection method. Patients who were readmitted or
dead within 1 year after discharge were excluded from
the analyses on readmission from year 2–5. Patients who
died or moved outside the area of the Western Norway
Regional Health Authorities before the end of follow-up
without any readmission were censored in the
Kaplan-Meier analysis and the Cox regression models.
All multivariate analyses were performed with stepwise
backward elimination starting with all significant param-
eters from the univariate analyses (P < .05). Age, sex and
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mRS score were forced into each analysis to adjust for
potential confounding. Statistical analyses were per-
formed using Stata 14.0 (Stata Corporation, College Sta-
tion, TX, USA).
Results
The study cohort included 1453 patients discharged alive
from our stroke unit, of whom 1303 (89.7%) were diag-
nosed with ischemic stroke and 150 (10.3%) were diag-
nosed with TIA. Baseline characteristics of the study
cohort are shown in Table 1.
Within 1 year after discharge from the index admis-
sion, 568 (39.1%) patients were readmitted and 163
(11.2%) patients were dead, of whom 108 (66.3%) had
been readmitted at least once. Of the 830 patients that
were alive and free of readmission 1 year after discharge,
439 (52.9%) were readmitted within 5 years. Figure 1
demonstrates the incidence estimates of readmission
over time. There were no differences in the 5-year inci-
dence of readmission between ischemic stroke and TIA.
After 5 years, a total of 1007 patients (69.3%) had been
readmitted, and 358 patients (24.6%) were alive and
without any readmission. A total of 492 patients (33.9%)
were dead wihtin 5 years after discharge, of whom 280
(56.9%) had been readmitted within 1 year and 124
(25.2%) had the first readmission during year 2–5.
Baseline characteristics of patients readmitted within
1 year and patients with the first readmission between
year 2–5 are shown in Table 2. On univariate analysis,
patients readmitted within 1 year were older, had a
poorer short-term functional outcome, a higher dis-
charge NIHSS score, and more complications during
index admission than patients with the first readmission
between year 2–5. A stroke subtype of small vessel oc-
clusion was more frequent in patients with the first re-
admission between year 2–5. Cardiovascular risk factors
and comorbidity did not differ between the two groups
of readmitted patients, and neither did prescribed sec-
ondary preventive treatment at discharge or at the time
of the first readmission. A higher percentage of patients
readmitted within the first year had stopped smoking be-
fore the index admission, whereas more patients had
quit smoking after the index admission in patients that
were readmitted between years 2–5. Of the patients that
were smoking at the time of the index stroke, 37% of the
patients readmitted between year 2–5 had stopped
smoking compared to 28% of patients readmitted during
the first year (p = 0.144). Patients readmitted within 1
year were more often discharged to nursing homes and
less often discharged home without help than patients
readmitted between year 2–5.
Increasing age, poorer short-term functional outcome
(increasing mRS score), and a history of peripheral
artery disease, coronary artery disease, or hypertension,
independently increased the risk of readmission within
1 year after discharge, whereas a stroke subtype of small
vessel occlusion significantly decreased the risk of
Table 1 Baseline characteristics of the study cohort
Characteristics Values
Age (years), mean ± SD 73.1 ± 13.7
Male sex, N (%) 782 (53.8)
NIHSS score at discharge, median (IQR) 1 (0, 4)
mRS score at discharge, median (IQR) 2 (1, 3)
Barthel Index at discharge, median (IQR) 100 (70, 100)
Stroke subtype, N (%)
Large-artery atherosclerosis 193 (13.3)
Cardioembolism 473 (32.6)
Small vessel occlusion 159 (10.9)
Other determined etiology 20 (1.4)
Undetermined etiology 608 (41.8)
Comorbidity, N (%)
Prior stroke 299 (20.6)
Peripheral artery disease 102 (7.0)
Coronary artery disease 325 (22.4)
Diabetes mellitus 211 (14.5)
Atrial fibrillation 428 (29.5)
Hypertension 813 (56.0)
Ever-smoker 832 (57.3)
Complications during index admission, N (%)
Pneumonia 112 (7.7)
Enteral feeding 117 (8.1)
Urinary tract infection 184 (12.7)
Urinary retention 327 (22.5)
Urinary incontinence 212 (14.6)
Seizures 35 (2.4)
Stroke in progression 130 (9.0)
Any complication 599 (41.2)
Length of stay, median (IQR) 6 (3, 11)





Discharge status, N (%)
Home without care 792 (54.6)
Home with care 164 (11.3)
Rehabilitation department 112 (7.7)
Nursing home 337 (23.2)
Other department 46 (3.2)
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readmission within 1 year (Table 3). Increasing age,
poorer short-term functional outcome, a history of cor-
onary artery disease, atrial fibrillation, or hypertension,
independently increased the risk of readmission between
year 2–5 if alive and free of readmission 1 year after dis-
charge (Table 4).
The most frequent cause of the first readmission
within 1 year was infection, followed by recurrent stroke,
stroke-related event and cardiac disease In contrast, car-
diac disease was the most frequent cause of the first re-
admission for patients readmitted during years 2–5,
followed by infection, stroke-related event and recurrent
stroke (Table 5).
Discussion
We found that 69.3% were readmitted within 5 years
after ischemic stroke or TIA, with more than half of
all readmitted patients presenting during the first
year. A smaller Norwegian study demonstrated that
56% of all readmissions within 10 years presented dur-
ing the first year after stroke and similar patterns
have been reported from the US [4–6]. In line with
previously reported 1-year readmission rates between
31 and 55%, we found that 39% were readmitted
within the first year after discharge [2, 3, 6, 15, 16].
The high rates of readmission during the first year
after stroke might reflect an increased vulnerability
for post-stroke complications such as infections, re-
current stroke and other cardiovascular events in the
early phase after stroke [1].
We also found that more than half of all patients that
survived for 1 year without any readmission were re-
admitted within 5 years. The frequency of the different
causes of readmission varied slightly depending on the
timing of the first readmission, but infection, cardiac dis-
ease, recurrent stroke and stroke-related events were the
four most common causes in both time periods. Higher
age, poor functional outcome, hypertension and coron-
ary artery disease were all independently associated with
readmission both within 1 year and during year 2–5.
This indicates that even if the patients survive the vul-
nerable early period after stroke, they still have a high
risk of readmission for the same causes as patients re-
admitted during the first year after stroke, and the same
factors might impact the risk of readmission also in the
more chronic phase after stroke.
Higher age and poorer short-term functional outcome
predicted readmission within 1 year and from year 2-5,
but patients readmitted within 1 year were older, had a
poorer short-term functional outcome and more compli-
cations during index admission than patients readmitted
later. Complications during the index stroke admission
have been associated with early readmission in several
studies, and probably relates to both high age and poor
functional outcome [17, 18]. Higher age and poor func-
tional outcome have been identified as predictors for re-
admission after stroke in several other studies [2, 7–11].
Although age is a non-modifiable risk factor for readmis-
sion, a focus on improving and maintaining physical func-
tion and mobility during the stroke hospitalization and in
the period after discharge for patients at all ages is import-
ant and could potentially help prevent some readmissions.
Hypertension and coronary artery disease were identi-
fied as common predictors of readmission within 1 year
and from year 2-5, and contrary to our hypothesis, the
vascular risk factor profile was not more prominent in
patients readmitted within 1 year. Hypertension and cor-
onary artery disease are important risk factors for
Fig. 1 Kaplan Meier failure curves showing incidence estimates of readmission within 5 years for patients with ischemic stroke (n= 1303) or TIA (n= 150)
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Age (years), mean ± SD 76.2 ± 12.5 73.3 ± 13.1 < 0.001
Male sex, N (%) 298 (52.5) 242 (55.1) 0.401
NIHSS score at discharge, median (IQR) 2 (0, 5) 1 (0, 3) < 0.001
mRS score at discharge, N (%) < 0.001
0–2 323 (56.9) 304 (69.3)
3–5 245 (43.1) 135 (30.8)
Barthel Index at discharge, median (IQR) 100 (60, 100) 100 (85, 100) < 0.001
Stroke diagnosis, N (%) 0.992
Ischemic stroke 510 (89.8) 395 (90.0)
TIA 58 (10.2) 44 (10.0)
Stroke subtype, N (%) 0.070
Large-artery atherosclerosis 85 (15.0) 53 (12.1)
Cardioembolism 206 (36.3) 152 (34.6)
Small vessel occlusion 44 (7.8) 55 (12.5)
Other determined etiology 8 (1.4) 3 (0.7)
Undetermined etiology 225 (39.6) 176 (40.1)
Comorbidity, N (%)
Prior stroke 137 (24.1) 96 (21.9) 0.401
Peripheral artery disease 54 (9.5) 29 (6.6) 0.097
Coronary artery disease 162 (28.5) 103 (23.5) 0.071
Diabetes mellitus 97 (17.1) 64 (14.6) 0.283
Atrial fibrillation 197 (34.7) 135 (30.8) 0.188
Hypertension 358 (63.0) 256 (58.3) 0.128
Ever-smoker 384 (67.6) 285 (64.9) 0.371
Complications during index admission, N (%)
Pneumonia 54 (9.5) 22 (5.0) 0.007
Enteral feeding 59 (10.4) 24 (5.5) 0.005
Urinary tract infection 86 (15.1) 49 (11.2) 0.066
Urinary retention 154 (27.1) 76 (17.3) < 0.001
Urinary incontinence 107 (18.8) 47 (10.7) < 0.001
Seizures 17 (3.0) 9 (2.1) 0.350
Stroke in progression 59 (10.4) 25 (5.7) 0.008
Any complication 281 (49.5) 157 (35.8) < 0.001
Length of stay, median (IQR) 6 (3, 11) 6 (3, 10) 0.190
Discharge status, N (%) < 0.001
Home without care 257 (45.4) 255 (58.1)
Home with care 84 (14.8) 57 (13.0)
Rehabilitation department 37 (6.5) 35 (8.0)
Nursing home 162 (28.6) 83 (18.9)
Other department 26 (4.6) 9 (2.1)
Treatment at discharge, N (%)
Platelet inhibitor 379 (66.7) 302 (68.8) 0.487
Anticoagulation 203 (35.7) 148 (33.7) 0.805
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recurrent stroke and cardiac disease, which were fre-
quent causes of readmission within both 1 year and year
2-5 in our study, and are highly important causes of
death after stroke [19, 20]. Hypertension is the most im-
portant modifiable risk factor for stroke and other car-
diovascular diseases, and blood pressure reduction
reduces the risk of recurrent stroke, myocardial infarc-
tion and cardiovascular death after stroke [21]. This em-
phasizes the importance of accurate and aggressive
treatment of cardiovascular risk factors in preventing
new vascular events and vascular mortality after ische-
mic stroke and TIA.
Even though cardiovascular risk factors did not differ
significantly between patients readmitted within 1 year
and patients readmitted during year 2–5, recurrent stroke
and stroke-related events were more frequent causes of
readmission within 1 year, whereas cardiac disease was a
more frequent cause of readmission for patients that were
readmitted during year 2–5. We have only included the
cause of the first uplanned readmission in this study, but
studies have shown similar results in relation to recurrent
stroke and cardiac disease, with the highest incidences of
recurrent stroke observed in the early period after stroke,
and lower, yet more stable, yearly incidences of myocardial
infarction and congestive heart failure [4, 22].
Even though they differ in functional outcome, ische-
mic stroke and TIA patients did not differ in the inci-
dence of readmission. Compared to ischemic stroke
patients, both lower, similar and higher rates of readmis-
sion in TIA patients have been reported [8, 23–25]. This
could possibly be explained by differences in case mix
and use of secondary prevention and adherence to med-
ical treatment [25]. Nevertheless, TIA patients have the
same risk factor profile and underlying causes of their is-
chemic event as patients with ischemic stroke, and
should be provided accurate secondary treatment in
order to reduce subsequent vascular events and
readmissions.
Our study has some limitations. Some patients may
have been readmitted to a hospital outside the region of
the Western Norwegian Regional Health authorities,
even though this region involves a large geographical
area of Western Norway. Furthermore, we have no
information on smoking status or medical treatment re-
ceived after discharge in patients that were not
readmitted, and no information on treatment
Table 2 Distribution of baseline characteristics between patients readmitted within 1 year and patients with the first readmission






Antihypertensive drug 363 (63.9) 285 (64.9) 0.740
Statins 390 (68.7) 322 (73.4) 0.105
Treatment at readmission, N (%)
Platelet inhibitor 368 (64.8) 281 (64.0) 0.798
Anticoagulation 211 (37.2) 151 (34.4) 0.367
Antihypertensive drug 371 (65.3) 286 (65.2) 0.956
Statins 365 (64.3) 267 (60.8) 0.263
Smoking status at readmission, N (%) 0.036
Stopped smoking before index stroke 242 (66.1) 160 (58.0)
Stopped smoking after index stroke 35 (9.6) 43 (15.6)
Still smoking at readmission 89 (24.3) 73 (26.5)
Table 3 Risk factors for readmission within 1 year after ischemic
stroke or TIA
Hazard Ratio 95% Confidence Interval P
Age, years 1.02 1.01–1.03 <.001
Male sex 1.02 0.86–1.21 .835
mRS score 1.15 1.09–1.22 <.001
Small vessel occlusion 0.67 0.49–0.91 .010
Peripheral artery disease 1.42 1.06–1.89 .018
Coronary artery disease 1.29 1.07–1.57 .009
Hypertension 1.26 1.05–1.50 .012
Table 4 Risk factors for readmission between year 2-5 if alive
and without readmission 1 year after ischemic stroke or TIA
Hazard Ratio 95% Confidence Interval P
Age, years 1.03 1.02–1.04 <.001
Male sex 1.13 0.93–1.38 .217
mRS score 1.09 1.02–1.16 .014
Coronary artery disease 1.50 1.20–1.89 <.001
Atrial fibrillation 1.25 1.01–1.55 .046
Hypertension 1.38 1.13–1.68 .001
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compliance. As the study cohort originates from a single
site, the generalizability of our findings may be limited.
A strength of our study is the ascertainment of data re-
lated to the readmissions made by review of medical re-
cords, and the inclusion of a relatively large study
population investigated in a single stroke center accord-
ing to a predefined protocol with comprehensive data
collection. Although other studies have reported resem-
bling results regarding rates and causes of long-term re-
admission after stroke, our study elaborates on existing
knowledge by describing rates, causes and predictors of
readmission for patients who survive the first year after
stroke without any readmission.
Conclusions
More than half of all patients who survived the first year
after stroke without any readmission, were readmitted
within 5 years. Patients with the first readmission during
year 2–5 after discharge shared several risk factors with
patients readmitted within 1 year, but they differed in
relation to short-term functional outcome, age, and the
frequency of complications during index admission. Our
results indicate that further improvement in the effort of
reducing post-stroke complications and hospital read-
missions should continue beyond the acute phase after
stroke. More studies are needed to establish predictors
of readmission after stroke in the long-term perspective.
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